Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.
about
Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationMalaria Parasites: The Great EscapeMicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma.Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious DiseasesIFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study.Immune checkpoints and their inhibition in cancer and infectious diseases.PD1 signal transduction pathways in T cells.ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control.Immune checkpoint blockade in infectious diseases.Controlled Human Malaria Infection: Applications, Advances and Challenges.Evaluating anti-disease immunity to malaria and implications for vaccine design.Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis.The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.PD-L1 inhibitors in the pipeline: Promise and progress.Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.Advanced non-small cell lung cancer: the role of PD-L1 inhibitors.IL-10 Producing B Cells Ability to Induce Regulatory T Cells Is Maintained in Rheumatoid Arthritis.Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency
P2860
Q28074536-0AB48EEC-4442-4B5A-9472-DDA8CD4E42C1Q28080325-62B6F549-CFE7-4186-A4FE-7979F0497E5EQ33709601-FD2E7FE7-645F-44A8-A4F9-E15EDA81A2B4Q33849778-F667491E-5A3E-45E4-84E2-E967B99F6446Q36182425-1F7D720A-5C6C-4A69-AB72-110FD4FB3F5DQ37578777-7A859285-ABA5-4E16-B964-78E23C902132Q38845026-839F2809-0C09-4ADD-AD88-D5065D8A2D7AQ40062424-B3050603-FB0D-43B5-8843-8415994866A6Q40118341-4A123FBC-5520-472A-92B3-4D62A6F90AE5Q41921732-1FCDE67E-3C39-4E8C-8250-1152A3D72A5BQ44168331-CF4A10DD-E66D-46DD-9357-9CC41811B1FFQ46222698-9EBE90A2-1255-49D7-ADD4-8AEC838C525AQ47112946-ADD15E44-E705-46FA-AEEC-F4D0EFB2FA5CQ47616839-49962668-0637-40E4-963A-A9A0CC329EA2Q48620175-3819C1FC-D7B6-4ED8-8CA9-28BFB193D26DQ52731766-793207CE-F07E-46C9-9924-86B6521F2431Q55174561-7B79D1F3-E311-462F-8058-3CC4AC92B1F9Q55316781-318F894F-1674-4C83-BB0A-84EB67ECB035Q55351430-8888FD86-280F-43AF-9DA1-4C19B8C0610CQ58003757-D478A907-425F-4FA1-B2F9-C61C155C9813
P2860
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Programmed Death-1 Ligand 2-Me ...... ishing CD4(+) T Cell Immunity.
@en
type
label
Programmed Death-1 Ligand 2-Me ...... ishing CD4(+) T Cell Immunity.
@en
prefLabel
Programmed Death-1 Ligand 2-Me ...... ishing CD4(+) T Cell Immunity.
@en
P2093
P50
P1433
P1476
Programmed Death-1 Ligand 2-Me ...... ishing CD4(+) T Cell Immunity.
@en
P2093
Arlene H Sharpe
Chek Meng Poh
Chiuan Yee Leow
Derek Richard
Deshapriya S Karunarathne
Fiona Amante
James S McCarthy
Joshua M Horne-Debets
Michael Yarski
Michelle N Wykes
P304
P356
10.1016/J.IMMUNI.2016.07.017
P407
P577
2016-08-01T00:00:00Z